Logo

OncoBlast-Precision Oncology in GU Malignancies: Applying Biomarkers to Clinical Practice

This CME-accredited, case-based activity is designed to enhance clinical decision-making through the application of current evidence and best practices in GU oncology. Learners will engage with interactive scenarios that emphasize personalized treatment approaches, safe use of emerging therapies, and effective management of treatment-related toxicities.

Course Accreditations

Course Summary

Events StartsEvents Ends
1/1/202512/31/2025

    Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology residents/fellows
  • Oncology NPs/PAs
  • Oncology pharmacists
  • Oncology nurses

    Learning Objectives

    Upon successful completion of this educational activity, participants will be able to:

  • Evaluate current evidence to inform treatment decisions in patients with advanced genitourinary cancers.
  • Integrate biomarker testing into clinical practice to guide personalized therapy.
  • Recognize and manage adverse effects associated with novel targeted therapies.